US evaluations of MedTronic's beStent begin:
This article was originally published in Clinica
Clinical evaluation has begun of MedTronic's new coronary stent system, the beStent Rival. One of the 15mm-long devices was implanted in a woman at Johns Hopkins Hospital in Maryland. The beStent is an expandable mesh, delivered pre-mounted on a balloon catheter. It is flexible during delivery but does not shorten when expanded, says MedTronic. Pre-mounted and self-mounted versions are already available outside the US (Clinica No 731, p 17).
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.